Synopsis
Synopsis
0
VMF
0
Canada
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 679 Br, Ba
2. 7-((hydroxybis(2-thienyl)acetyl)oxy)-9,9-dimethyl-3-oxa-9-azoniatricyclo(3.3.1.0(2,4))nonane Bromide
3. Ba 679 Br
4. Ba-679 Br
5. Ba679 Br
6. Br, Ba 679
7. Bromide, Tiotropium
8. Spiriva
9. Tiotropium
1. 136310-93-5
2. Spiriva
3. Ba 679 Br
4. Tiotropium (bromide)
5. Spiriva Handihaler
6. Ba 679br
7. Ba-679 Br
8. Spiriva Respimat
9. (1r,2r,4s,5s,7s)-7-(2-hydroxy-2,2-di(thiophen-2-yl)acetoxy)-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium Bromide
10. Xx112xzp0j
11. Chembl4638964
12. 7-((hydroxybis(2-thienyl)acetyl)oxy)-9,9-dimethyl-3-oxa-9-azoniatricyclo(3.3.1.0(2,4))nonane Bromide
13. Ba-679-br
14. (1r,2r,4s,5s,7r)-7-{[2-hydroxy-2,2-bis(thiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.0^{2,4}]nonan-9-ium Bromide
15. (1r,2r,4s,5s,7s)-7-(2-hydroxy-2,2-di(thiophen-2-yl)acetoxy)-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.0
16. Tiopropium
17. Tiotropium Bromide Anhydrous
18. Ba-679br
19. (1a,2b,4b,5a,7b)-7-[(hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane Bromide
20. Ncgc00167971-01
21. Tiotropium Bromide [inn]
22. Unii-xx112xzp0j
23. Tiotropium Bromide [usan:inn:ban]
24. Tiotropium Bromide- Bio-x
25. Schembl8625
26. Dsstox_cid_24214
27. Dsstox_rid_80122
28. Dsstox_gsid_44214
29. Schembl440873
30. Schembl7607795
31. Tiotropium Bromide [mi]
32. Chembl3189058
33. Chembl4440620
34. Dtxsid2044214
35. Chebi:90959
36. Tiotropium Bromide [usan]
37. Hms2090h20
38. Act04740
39. Act04741
40. Amy23428
41. Bcp02925
42. Tiotropium Bromide [who-dd]
43. Tox21_112598
44. Bdbm50538220
45. Mfcd00867027
46. Akos015920264
47. Akos025400979
48. Ac-1300
49. Cs-0903
50. Ks-1402
51. Tiotropium Bromide [orange Book]
52. Tiotropium Bromide(spiriva, Ba 679br)
53. As-75172
54. Bt164474
55. Hy-17360
56. Bcp0726000293
57. Cas-136310-93-5
58. T3032
59. A846824
60. Q27162952
61. (1?,2?,4?,5?,7?)-7-[(2-hydroxy-2,2-di-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane Bromide
62. (1alpha,2beta,4beta,5alpha,7beta)-7-[(hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0(2,4)]nonane Bromide
63. (1r,2r,4s,5s)-7-{[2-hydroxy-2,2-bis(thiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.0(2),?]nonan-9-ium Bromide
64. (1r,2r,4s,5s,7r)-7-{[2-hydroxy-2,2-bis(thiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.0?,?]nonan-9-ium Bromide
65. (1r,2r,4s,5s,7s)-7-[2-hydroxy-2,2-di(2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium Bromide
66. [(1r,2r,4s,5s)-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] 2-hydroxy-2,2-dithiophen-2-ylacetate;bromide
67. [(1r,2r,4s,5s)-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl]2-hydroxy-2,2-dithiophen-2-yl-acetate Bromide
68. 1.alpha., 2.beta., 4.beta, 5.alpha, 7.beta-7-((hydroxydi-2-thienylacetyl)oxy)-9,9-dimethyl-3-oxa-9-azoniatricyclo(3.3.1.0 Sup(2,4))nonane Bromide
69. 3-oxa-9-azoniatricyclo(3,3.1.0(2,4))nonane, 7-((hydroxydi-2-thienylacetyl)oxy)-9,9-dimethyl-, Bromide, (1alpha,2beta,4beta,5alpha,7beta)-
70. 3-oxa-9-azoniatricyclo(3.3.1.02,4)nonane, 7-((hydroxydi-2-thienacetyl)oxy)-9,9-dimethyl-, Bromide, (1.alpha.,2.beta.,4.beta.,5.alpha.,7.beta.)-
71. 3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane, 7-[(2-hydroxy-2,2-di-2-thienylacetyl)oxy]-9,9-dimethyl-, Bromide (1:1), (1alpha,2beta,4beta,5alpha,7beta)-
72. 6.beta.,7.beta.-epoxy-3.beta.-hydroxy-8-methyl-1.alpha.h,5.alpha.h-tropanium Bromide, Di-2-thienylglycolate
73. Rel-(1r,2r,4s,5s,7s)-7-(2-hydroxy-2,2-di(thiophen-2-yl)acetoxy)-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium Bromide
74. Rel-(1r,2r,4s,5s,7s)-7-(2-hydroxy-2,2-di(thiophen-2-yl)acetoxy)-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-iumbromide
1. Tiotropiumbromide
2. Gsp 304
3. Tiotropium Cation
4. Respimat
Molecular Weight | 472.4 g/mol |
---|---|
Molecular Formula | C19H22BrNO4S2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 5 |
Exact Mass | 471.01736 g/mol |
Monoisotopic Mass | 471.01736 g/mol |
Topological Polar Surface Area | 116 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 564 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Spiriva |
PubMed Health | tiotropium |
Drug Classes | Bronchodilator |
Drug Label | SPIRIVA HandiHaler consists of a capsule dosage form containing a dry powder formulation of tiotropium intended for oral inhalation only with the HandiHaler device.Each light green, hard gelatin SPIRIVA capsule contains 18 mcg tiotropium (equivalent... |
Active Ingredient | Tiotropium bromide |
Dosage Form | Powder |
Route | Inhalation |
Strength | eq 0.018mg base/inh |
Market Status | Prescription |
Company | Boehringer Ingelheim |
Patent | 8022082; 6908928; RE38912; 7694676; RE39820; 7309707; 7642268; 7070800; 6777423 |
2 of 4 | |
---|---|
Drug Name | Spiriva respimat |
PubMed Health | tiotropium |
Drug Label | The active component of SPIRIVA RESPIMAT is tiotropium. The drug substance, tiotropium bromide monohydrate, is an anticholinergic with specificity for muscarinic receptors. It is chemically described as (1, 2, 4, 5, 7)-7-[(Hydroxydi-2-thien... |
Active Ingredient | Tiotropium bromide |
Dosage Form | Spray, metered |
Route | Inhalation |
Strength | eq 0.0025mg base/inh |
Market Status | Prescription |
Company | Boehringer Ingelheim |
Patent | 7284474; 7802568; 6977042; 5964416; 7988001; 6176242; 6453795; RE39820; 7246615; 6988496; 7896264; 7837235; 6726124; 6846413; 6149054; 7396341; 7104470 |
3 of 4 | |
---|---|
Drug Name | Spiriva |
PubMed Health | tiotropium |
Drug Classes | Bronchodilator |
Drug Label | SPIRIVA HandiHaler consists of a capsule dosage form containing a dry powder formulation of tiotropium intended for oral inhalation only with the HandiHaler device.Each light green, hard gelatin SPIRIVA capsule contains 18 mcg tiotropium (equivalent... |
Active Ingredient | Tiotropium bromide |
Dosage Form | Powder |
Route | Inhalation |
Strength | eq 0.018mg base/inh |
Market Status | Prescription |
Company | Boehringer Ingelheim |
Patent | 8022082; 6908928; RE38912; 7694676; RE39820; 7309707; 7642268; 7070800; 6777423 |
4 of 4 | |
---|---|
Drug Name | Spiriva respimat |
PubMed Health | tiotropium |
Drug Label | The active component of SPIRIVA RESPIMAT is tiotropium. The drug substance, tiotropium bromide monohydrate, is an anticholinergic with specificity for muscarinic receptors. It is chemically described as (1, 2, 4, 5, 7)-7-[(Hydroxydi-2-thien... |
Active Ingredient | Tiotropium bromide |
Dosage Form | Spray, metered |
Route | Inhalation |
Strength | eq 0.0025mg base/inh |
Market Status | Prescription |
Company | Boehringer Ingelheim |
Patent | 7284474; 7802568; 6977042; 5964416; 7988001; 6176242; 6453795; RE39820; 7246615; 6988496; 7896264; 7837235; 6726124; 6846413; 6149054; 7396341; 7104470 |
Cholinergic Antagonists
Drugs that bind to but do not activate CHOLINERGIC RECEPTORS, thereby blocking the actions of ACETYLCHOLINE or cholinergic agonists. (See all compounds classified as Cholinergic Antagonists.)
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
Bronchodilator Agents
Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)
R03BB04
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
R - Respiratory system
R03 - Drugs for obstructive airway diseases
R03B - Other drugs for obstructive airway diseases, inhalants
R03BB - Anticholinergics
R03BB04 - Tiotropium bromide
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
A Tiotropium bromide anhydrous manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tiotropium bromide anhydrous, including repackagers and relabelers. The FDA regulates Tiotropium bromide anhydrous manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tiotropium bromide anhydrous API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tiotropium bromide anhydrous manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tiotropium bromide anhydrous supplier is an individual or a company that provides Tiotropium bromide anhydrous active pharmaceutical ingredient (API) or Tiotropium bromide anhydrous finished formulations upon request. The Tiotropium bromide anhydrous suppliers may include Tiotropium bromide anhydrous API manufacturers, exporters, distributors and traders.
click here to find a list of Tiotropium bromide anhydrous suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tiotropium bromide anhydrous DMF (Drug Master File) is a document detailing the whole manufacturing process of Tiotropium bromide anhydrous active pharmaceutical ingredient (API) in detail. Different forms of Tiotropium bromide anhydrous DMFs exist exist since differing nations have different regulations, such as Tiotropium bromide anhydrous USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tiotropium bromide anhydrous DMF submitted to regulatory agencies in the US is known as a USDMF. Tiotropium bromide anhydrous USDMF includes data on Tiotropium bromide anhydrous's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tiotropium bromide anhydrous USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tiotropium bromide anhydrous suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Tiotropium bromide anhydrous Drug Master File in Japan (Tiotropium bromide anhydrous JDMF) empowers Tiotropium bromide anhydrous API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Tiotropium bromide anhydrous JDMF during the approval evaluation for pharmaceutical products. At the time of Tiotropium bromide anhydrous JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Tiotropium bromide anhydrous suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Tiotropium bromide anhydrous Drug Master File in Korea (Tiotropium bromide anhydrous KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Tiotropium bromide anhydrous. The MFDS reviews the Tiotropium bromide anhydrous KDMF as part of the drug registration process and uses the information provided in the Tiotropium bromide anhydrous KDMF to evaluate the safety and efficacy of the drug.
After submitting a Tiotropium bromide anhydrous KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Tiotropium bromide anhydrous API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Tiotropium bromide anhydrous suppliers with KDMF on PharmaCompass.
A Tiotropium bromide anhydrous CEP of the European Pharmacopoeia monograph is often referred to as a Tiotropium bromide anhydrous Certificate of Suitability (COS). The purpose of a Tiotropium bromide anhydrous CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Tiotropium bromide anhydrous EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Tiotropium bromide anhydrous to their clients by showing that a Tiotropium bromide anhydrous CEP has been issued for it. The manufacturer submits a Tiotropium bromide anhydrous CEP (COS) as part of the market authorization procedure, and it takes on the role of a Tiotropium bromide anhydrous CEP holder for the record. Additionally, the data presented in the Tiotropium bromide anhydrous CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Tiotropium bromide anhydrous DMF.
A Tiotropium bromide anhydrous CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Tiotropium bromide anhydrous CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Tiotropium bromide anhydrous suppliers with CEP (COS) on PharmaCompass.
A Tiotropium bromide anhydrous written confirmation (Tiotropium bromide anhydrous WC) is an official document issued by a regulatory agency to a Tiotropium bromide anhydrous manufacturer, verifying that the manufacturing facility of a Tiotropium bromide anhydrous active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Tiotropium bromide anhydrous APIs or Tiotropium bromide anhydrous finished pharmaceutical products to another nation, regulatory agencies frequently require a Tiotropium bromide anhydrous WC (written confirmation) as part of the regulatory process.
click here to find a list of Tiotropium bromide anhydrous suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tiotropium bromide anhydrous as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Tiotropium bromide anhydrous API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Tiotropium bromide anhydrous as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Tiotropium bromide anhydrous and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tiotropium bromide anhydrous NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Tiotropium bromide anhydrous suppliers with NDC on PharmaCompass.
Tiotropium bromide anhydrous Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tiotropium bromide anhydrous GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tiotropium bromide anhydrous GMP manufacturer or Tiotropium bromide anhydrous GMP API supplier for your needs.
A Tiotropium bromide anhydrous CoA (Certificate of Analysis) is a formal document that attests to Tiotropium bromide anhydrous's compliance with Tiotropium bromide anhydrous specifications and serves as a tool for batch-level quality control.
Tiotropium bromide anhydrous CoA mostly includes findings from lab analyses of a specific batch. For each Tiotropium bromide anhydrous CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tiotropium bromide anhydrous may be tested according to a variety of international standards, such as European Pharmacopoeia (Tiotropium bromide anhydrous EP), Tiotropium bromide anhydrous JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tiotropium bromide anhydrous USP).
LOOKING FOR A SUPPLIER?